The AIM-listed immunotherapy specialist will present three posters at the AAAAI Annual Meeting in Philadelphia this week ...

By type, the subcutaneous immunotherapy segment held the highest share in the year 2023. Subcutaneous immunotherapy helps reduce allergy symptoms. It is known to offer sustained relief even after ...

Neurent Medical today announced positive findings from a randomized controlled trial evaluating its Neuromark system.

Montelukast is a leukotriene receptor antagonist approved for the prophylactic and chronic treatment of asthma and the relief of allergic rhinitis.

Neurent Medical, a leader in non-surgical treatments for chronic rhinitis, today announced the publication of positive results from its randomized controlled trial (RCT) evaluating the NEUROMARK® ...

A new study published in Science suggests a single nasal spray vaccine may protect against colds, flu, bacterial lung ...

My sinuses have been bunged up for years. I'm constantly blowing my nose. I use nasal decongestants but those don't seem to ...

Changes of season can be refreshing, but when it comes to your lungs, they can pose unseen dangers. With increased cases of pollution, infection, and allergens, every season poses its own threat to ...

BROADEN2 Phase 2b trial in atopic dermatitis (AD) ongoing, with data expected by mid-2027KT-621 BREADTH Phase 2b trial in asthma ...

Respiratory physicians Dr Hannah Petty and Dr Nita Sehgal discuss management of treatment resistant asthma in primary care ...

Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, announces the closing of $10.7M in new financing. The Series A round was led by MedVenture ...

Biorep Technologies, a leading medical device contract design and manufacturing organization (CDMO) with more than 30 years ...